Emapalumab Effective in Rheumatologic Disease–Associated HLH
Emapalumab-containing regimens showed positive outcomes in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis, a rare and life-threatening disorder.
Medscape Medical News
source https://www.medscape.com/viewarticle/emapalumab-effective-rheumatologic-disease-associated-2024a1000hgq?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/emapalumab-effective-rheumatologic-disease-associated-2024a1000hgq?src=rss
Comments
Post a Comment